Evidence map›Paper›PMID 36982192›Full record

ArticleInternational journal of molecular sciences2023

Imaging Mass Spectrometry for the Classification of Melanoma Based on

Rita Casadonte, Mark Kriegsmann, Katharina Kriegsmann, Helene Streit, Rolf Rüdiger Meliß, Cornelia S L Müller, Joerg Kriegsmann

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Rita CasadonteProteopath GmbH, 54296 Trier, Germany.ORCID 0000-0002-9054-4786
Mark KriegsmannInstitute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0002-7319-3646
Katharina KriegsmannDepartment of Hematology Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Helene StreitDepartment of Medicine, Faculty of Medicine and Dentistry, Danube Private University, 3500 Krems, Austria.
Rolf Rüdiger MelißInstitute für Dermatopathologie, 30519 Hannover, Germany.
Cornelia S L MüllerMVZ für Histologie, Zytologie und Molekulare Diagnostik Trier, 54296 Trier, Germany.ORCID 0000-0002-7656-721X
Joerg KriegsmannProteopath GmbH, 54296 Trier, Germany.
Danube Private University · ATHeidelberg University · DEZentrum für Pathologie und Zytodiagnostik · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations of the oncogenes v-raf murine sarcoma viral oncogene homolog B1 (

Indexed as

MelanomaSkin NeoplasmsAnimalsGTP PhosphohydrolasesHumansMass SpectrometryMembrane ProteinsMiceMitogen-Activated Protein Kinase KinasesMutationProtein Kinase InhibitorsProteomicsProto-Oncogene Proteins B-rafBRAF protein, humanGTP PhosphohydrolasesMembrane ProteinsMitogen-Activated Protein Kinase KinasesNRAS protein, humanProtein Kinase InhibitorsProto-Oncogene Proteins B-rafBRAFclassificationdiagnostics: imaging mass spectrometryMALDImelanomaNRAS

Identifiers

PMID36982192
PMCPMC10049262
OpenAlexW4323566330

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read58
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.